Lanreotide Acetate 69097-0870
Product NDC
69097-0870- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 24, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA215395
Need to source Lanreotide Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lanreotide Acetate | 120 mg/.5mL |
Drug Class
Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]
Packaging Options(1)
1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE